Search

You searched for "field"

1280 results found
Ocular immunology and inflammation journal cover image.

Early biomarker for paraneoplastic retinopathy

1 October 2026 | | EYE - Oncology
This informative case series evaluates 4 eyes of 2 patients presenting with rapidly progressive vision loss secondary to cancer-associated retinopathy. The authors identified a distinct spectral-domain optical coherence tomography structural feature termed the angular sign of Henle fibre layer hyperreflectivity...
Ophthalmic drug delivery book cover image.

Ophthalmic drug delivery: Advancement, industrialization prospect and applications (1st Edition)

5 October 2026 | | EYE - General
This first edition addresses a key challenge in ophthalmology: effective drug delivery to the eye. It focuses on translating scientific advances into clinical and industrial practice, offering a comprehensive synthesis of contemporary research. Early chapters cover ocular anatomy, physiology and...

Glaucoma: 30 years on

30 November 2023
Back in 1993, the late and great Barry Cullen FRCS (Cavan born, Dublin trained), the first editor of Eye News, asked me to write an article about the current treatment of chronic open angle glaucoma (COAG). At the time I...

Simulating the visual impairment symptoms of age-related macular degeneration in virtual reality

5 June 2023 | | EYE - Vitreo-Retinal
A new virtual reality application visually simulates age-related macular degeneration and demonstrates its progression over time including some Charles Bonnet syndrome hallucinations. Introduction Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries with the prevalence of...

Optegra launches new fellowship programme

15 February 2024 | cataract, Fadi Alfaqawi, professional development
Leading eye health care group, Optegra, is proud to announce the appointment of its first Fellow, Mr Fadi Alfaqawi, as it unveils its Cataract and Refractive Surgery Fellowship Programme.

The results of the last survey Oct20

5 October 2020 | | EYE - Glaucoma, EYE - Cataract, EYE - Refractive, EYE - General
The point of this series is to find variations in practice and to raise them to you, the readership, so you can review and reflect upon them. I am aware there is not always a ‘correct’ way of doing things,...

The results of the last survey Jun23

5 June 2023 | | EYE - General
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. I continue...

A case of retinal cavernous haemangioma – don’t let it slip through the grapevine

4 December 2023 | | EYE - Vitreo-Retinal
We present a case of a seven-year-old male who presented to the emergency eye referral clinic with red eye. He was diagnosed and treated for allergic conjunctivitis, however, on clinic review, wide field retinal imaging was performed (as has been...

CALL TO ACTION: Help the Ridley Eye Foundation ‘reach more of the unreachable’ in the Himalayas

4 October 2023 |
On the 29 November 1949, Harold Ridley carried out the first implant of an intraocular lens (IoL). This was the first major breakthrough in the cure of cataract blindness since Jacques Daviel conducted the first extra-capsular extraction 198 years earlier....

Report on ‘2024: Artificial Intelligence and the Eye’

3 June 2024 | | EYE - General
As the application of artificial intelligence (AI) is brought to the foray of clinical medicine, you can be forgiven for thinking that it is a relatively recent technology. However, researchers and computer scientists have been working on it for many...

Ocular toxicity secondary to deferoxamine

12 June 2026 | | EYE - Pathology, EYE - Imaging, EYE - Vitreo-Retinal
Patients with myelodysplastic syndromes can develop transfusion-related iron overload as they become dependent on recurrent blood transfusions [1]. Iron chelation therapy is indicated for the treatment of iron overload and one established example of this is deferoxamine. However, deferoxamine ocular...

Celebrating eight years of the nurse-led intravitreal injection service

4 February 2021 | | EYE - Vitreo-Retinal, EYE - General
Moorfields Eye Hospital NHS Foundation Trust in London celebrated the eighth year of its nurse-led intravitreal (IVT) injection service in 2020. In collaboration with Beaver-Visitec International (BVI), Moorfields’ comprehensive one-day course for non-medical staff has blossomed into a thriving success....